Barron's Says Rindopepimut Accelerated Approval Drug Update in Feb. //////////////// Read
Perfect example why you do the DD. This is Celldex Accelerated Approval drug. This is huge, could be like ICPT and they could announce FDA granting Accelerated Approval.
Best Biotech Ideas for 2014
Celldex - In February, the company should provide an update on enrollment numbers in the pivotal phase IIIACT IV trial for rindopepimut in front-line [tumor specific oncogene] EGFRvIII+ glioblastoma (GBM) and report first clinical data for CDX-1135 in dense deposit disease (DDD).